CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

about

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

Item

http://www.wikidata.org/entity/Q42502215

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

@en

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

@nl

type

Item

label

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

@en

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

@nl

prefLabel

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

@en

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

@nl

P1476

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma

@en

P2093

Eloy Pomares-Navarro

http://www.w3.org/2001/XMLSchema#string

Enrique Lerma

http://www.w3.org/2001/XMLSchema#string

Fernando Ortiz-Martínez

http://www.w3.org/2001/XMLSchema#string

Gloria Peiró

http://www.w3.org/2001/XMLSchema#string

José M Sempere-Ortells

http://www.w3.org/2001/XMLSchema#string

Leire Andrés

http://www.w3.org/2001/XMLSchema#string

Marta García-Escolano

http://www.w3.org/2001/XMLSchema#string

Montserrat Rodrigo-Baños

http://www.w3.org/2001/XMLSchema#string

P2860

CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis

Global cancer statistics, 2012

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

A new mathematical model for relative quantification in real-time RT-PCR

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Prognostic value of CD44 variant expression in primary breast cancer.

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression

Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.

Choosing the right cell line for breast cancer research

P2888

s00428-016-2045-3

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-016-2045-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

470

http://www.w3.org/2001/XMLSchema#string

P50

Ignacio Aranda

Elena Sanmartín

Pascual Martínez-Peinado

Araceli García-Martínez

P577

2016-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1016336190

http://www.w3.org/2001/XMLSchema#string

P698

27885422

http://www.w3.org/2001/XMLSchema#string